HAC Pharma

H.A.C. Pharma is a French independent pharmaceutical Exploitant company. Since 2007, H.A.C. Pharma is delivering mature and innovative high value drugs to patients through distribution, in-licensing and acquisition deals. H.A.C. Pharma has unique end-to-end capabilities to market high therapeutic value drugs on the French market, especially in pathologies with reduced alternatives for the patient. H.A.C. Pharma is a partner of choice to integrate your products at any step of their lifecycle: from regulatory and market access strategy, to product importation and distribution, including marketing and sales strategy, when required. The companys drugs are promoted in France, with its own sales...

Specialty pharmaceuticals,early access,orphan drugs status,compassionate use,medical evaluation,market access,pricing and reimbursement,in-licensing,distribution,acquisitions,m&a,supply chain,tech transfer,cmo management,medical promotion,guidelines,product development,established brands,and innovative therapeutics

Hac pharma operates in the Pharmaceutical manufacturing industry.

Hac pharma's revenue is 11m - 100m

Hac pharma has 11 - 50 employees.